P. Majumder

发表

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

T. Golub, P. Febbo, J. Manola, 2004, Nature Medicine.

Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition

P. Majumder, Shiladitya Sengupta, A. Goldman, 2015, Nature Communications.

Regulation of the Rapamycin and FKBP-Target 1/Mammalian Target of Rapamycin and Cap-dependent Initiation of Translation by the c-Abl Protein-tyrosine Kinase*

A. Gingras, D. Sabatini, N. Sonenberg, 2000, The Journal of Biological Chemistry.

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity.

Sarat Chandarlapaty, Violeta Serra, Maurizio Scaltriti, 2011, Cancer cell.

MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo

P. Majumder, Hiroshi Sootome, H. Hirai, 2010, Molecular Cancer Therapeutics.

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity

Harikrishna Narasimhan, Shivani Agarwal, Shiladitya Sengupta, 2015, Nature Communications.

Targeting of protein kinase C delta to mitochondria in the oxidative stress response.

P. Majumder, D. Kufe, Xiangao Sun, 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Targeting of Protein Kinase C to Mitochondria in the Oxidative Stress Response 1

P. Majumder, D. Kufe, Xiangao Sun, 2001 .

Functional interaction between RAFT1/FRAP/mTOR and protein kinase Cδ in the regulation of cap‐dependent initiation of translation

D. Sabatini, P. Majumder, Madhur Kumar, 2000, The EMBO journal.

Bcl-xL Blocks Activation of Related Adhesion Focal Tyrosine Kinase/Proline-rich Tyrosine Kinase 2 and Stress-activated Protein Kinase/c-Jun N-terminal Protein Kinase in the Cellular Response to Methylmethane Sulfonate*

P. Majumder, A. Place, V. Kumar, 1999, The Journal of Biological Chemistry.

Mitochondrial Translocation of Protein Kinase C δ in Phorbol Ester-induced Cytochrome c Release and Apoptosis*

P. Majumder, D. Kufe, P. Pandey, 2000, The Journal of Biological Chemistry.

Activation of the Cytoplasmic c-Abl Tyrosine Kinase by Reactive Oxygen Species*

R. Weichselbaum, P. Majumder, S. Kumar, 2000, The Journal of Biological Chemistry.

Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells

P. Majumder, A. Bardia, H. Jang, 2021, Nature Nanotechnology.

Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response Dynamics

D. Doval, P. Majumder, S. Thiyagarajan, 2020, iScience.

Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase

T. Pandita, P. Majumder, D. Weaver, 2000, Current Biology.

p63 regulates commitment to the prostate cell lineage.

M. Loda, P. Kantoff, W. Sellers, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Prostate gland: Structure, functions and regulation

P. Majumder, V. Kumar, Manna P.K, 2007, International Urology and Nephrology.

Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer

P. Majumder, B. Majumder, N. Alam, 2022, Journal of Cell Communication and Signaling.

Androgen receptor mRNA detection in the human foetal prostate

P. Majumder, V. Kumar, 2007, International Urology and Nephrology.

Inhibitory effects of formaldehyde on the reproductive system of male rats.

P. Majumder, V. Kumar, V. Kumar, 1995, Indian journal of physiology and pharmacology.

Abstract #1751: MK-8033, a selective c-Met / Ron inhibitor, suppresses tumor cell growth in vitro and in vivo

P. Majumder, W. Lu, K. Kunii, 2009 .

Data Mining in High-Performance Computing: A Survey of Related Algorithms

Mohuya Chakraborty, Pradip Kumar Majumder, P. Majumder, 2018, Advances in Intelligent Systems and Computing.

Identification of prostate cancer modifier pathways using parental strain expression mapping

Todd R Golub, William R Sellers, Massimo Loda, 2007, Proceedings of the National Academy of Sciences.

Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma.

P. Majumder, Sreenath V. Sharma, J. Settleman, 2009, Gastroenterology.

Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancer.

P. Majumder, S. Kasibhatla, M. Angagaw, 2009, Cancer research.

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes.

P. Majumder, Willmar D. Patino, Zhiyong Lin, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.

P. Majumder, M. Kelliher, N. Hermance, 2009, Blood.

Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.

T. Yeatman, D. Coppola, P. Majumder, 2010, Cancer research.

Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators

P. Majumder, M. Bissonnette, S. Cerda, 2006, Oncogene.

Akt-regulated pathways in prostate cancer

W. Sellers, P. Majumder, 2005, Oncogene.

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model

Todd R. Golub, Jen Jen Yeh, Phillip G. Febbo, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells

T. Golub, W. Hahn, P. Febbo, 2004, Cancer Research.

A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.

W. Hahn, M. Loda, W. Sellers, 2008, Cancer cell.

Activation of p38 Mitogen-activated Protein Kinase by PYK2/Related Adhesion Focal Tyrosine Kinase-dependent Mechanism*

P. Majumder, P. Pandey, S. Kharbanda, 1999, The Journal of Biological Chemistry.

Human Prostate Epithelial Cells Androgen-Induced Differentiation and Tumorigenicity of Updated

T. Golub, W. Hahn, P. Febbo, 2004 .

Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance

P. Majumder, Shiladitya Sengupta, A. Goldman, 2019, Science Signaling.

BASIC—LIVER, PANCREAS, AND BILIARY TRACT Inhibition of -Secretase Activity Inhibits Tumor Progression in a Mouse Model of Pancreatic Ductal Adenocarcinoma

P. Majumder, Sreenath V. Sharma, J. Settleman, 2009 .

Experimental Therapeutics, Molecular Targets, and Chemical Biology De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model

P. Majumder, J. Watters, C. Winter, 2009 .

Evidence of mTOR Activation by an AKT-Independent Mechanism Provides Support for the Combined Treatment of PTEN-Deficient Prostate Tumors with mTOR and AKT Inhibitors.

C. Paweletz, P. Majumder, K. Kunii, 2012, Translational oncology.

Inhibition of rapamycin-induced AKT activation elicits differential antitumor response in head and neck cancers.

P. Majumder, S. Thiyagarajan, B. Majumder, 2013, Cancer research.

Antitumor Response in Head and Neck Cancers Inhibition of Rapamycin-Induced AKT Activation Elicits Differential

P. Majumder, S. Thiyagarajan, B. Majumder, 2013 .

Microenvironment and Immunology Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers

P. Majumder, S. Thiyagarajan, B. Majumder, 2013 .

Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer

A. Pandey, S. Navani, S. Pinto, 2020, Gastric Cancer.

Observations on EGFR gene amplification and polymorphism in prostatic diseases

P. Majumder, V. Kumar, 2004, International Urology and Nephrology.

Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate.

P. Majumder, S. Gujral, V. Kumar, 1998, Cancer letters.

CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer

P. Majumder, B. Majumder, J. Biswas, 2017, Cellular Oncology.

Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer

A. Krešo, P. Majumder, J. Hassell, 2012, Oncogene.

Androgen deprivation causes up-regulation of androgen receptor transcript in the rat prostate

P. Majumder, Vijay Kumar, 1997, Molecular and Cellular Biochemistry.

RESEARCH PAPER Down-regulation of the Notch pathway mediated by a g-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia

P. Majumder, C. Kenific, K. Kunii, 2009 .

Abstract #3714: In vitro and in vivo antitumor activities of MK-2206, a new allosteric Akt inhibitor

P. Majumder, K. Leander, H. Hatch, 2009 .

In vivo modulation of androgen receptor by androgens.

P. Majumder, V. Kumar, 2002, Asian journal of andrology.

Experimental Therapeutics, Molecular Targets, and Chemical Biology De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model

P. Majumder, J. Watters, C. Winter, 2009 .

A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.

W. Hahn, M. Loda, W. Sellers, 2008, Cancer cell.